NEWS
SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has signed a commercial supply agreement with Lantheus [...]
SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing
Dulles, VA, November 4, 2020 - SOFIE, whose vision is to improve patient outcomes by developing and delivering molecular [...]
FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
“This FDA approval signals another important advancement in the evaluation of Alzheimer’s Disease. With every such achievement the molecular [...]
A Message from our CEO, Patrick Phelps
With cases of COVID-19 spreading throughout the world and America, healthcare workers are on the frontlines of the pandemic [...]
Sofie Biosciences Enters Strategic Collaboration For The Production And Distribution Of FAPI Precursors
LOS ANGELES and RADEBERG, Germany, Oct. 10, 2019 /PRNewswire/ -- Sofie Biosciences, Inc. (SOFIE), a Theranostics company, announced today it has executed a [...]
SOFIE Co-Founder, President and CEO Patrick Phelps one of Biocom’s Life Science Catalyst Award Winners
From Biocom: SAN DIEGO--Biocom, the association representing the California life science industry, today announced the winners of its Fourth [...]